THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, today announced that the company will release financial results for the third quarter 2008 prior to the market opening on Thursday, October 23, 2008. Additionally, Opexa management will host a conference call and webcast at 8:30 a.m. Eastern on Thursday, October 23, 2008, to discuss the third quarter 2008 financial results and to provide an update on recent corporate developments.
